Sangamo BioSciences | Créances Commerciales





Créances Commerciales Changement Date
Alaunos Therapeutics USD 2K 0 2025-06
Alnylam Pharmaceuticals USD 964.77M 397.66M 2025-09
Alterity Therapeutics Limited AUD 8.67M 1.59M 2023-06
Amgen USD 9.57B 1.08B 2025-12
Bayer EUR 14.91B 2.73B 2025-09
BioCryst Pharmaceuticals USD 79.07M 6.61M 2024-12
Biogen USD 1.85B 234M 2025-09
BioMarin Pharmaceutical USD 790.27M 65.59M 2025-09
Cipla INR 74.61B 19.39B 2025-09
Clal Biotechnology ILS 3.75M 186K 2022-12
Compugen USD 2.83M 930K 2025-09
CSL USD 2.97B 638M 2025-06
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Grifols EUR 1.29B 83.03M 2025-09
Ionis Pharmaceuticals USD 24.61M 27.97M 2025-09
J&J USD 17.61B 235M 2025-09
Karyopharm Therapeutics USD 31.78M 6.82M 2024-09
Merck USD 12.12B 596M 2025-09
Novartis USD 8.98B 192M 2025-09
Omeros USD 8.08M 440K 2024-06
Pfizer USD 18.12B 2.02B 2025-09
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 397M 100M 2025-12
Sarepta Therapeutics USD 395.74M 213.86M 2025-09
Tectonic Therapeutic USD 0 270K 2023-12
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Vertex Pharmaceuticals USD 1.95B 52.9M 2025-09


Sangamo BioSciences Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.